Showing 1 - 14 results of 14 for search 'Jeff M. Michalski', query time: 0.05s
Refine Results
-
1
-
2
Abscopal Effect Following Proton Beam Radiotherapy in a Patient With Inoperable Metastatic Retroperitoneal Sarcoma by Randall J. Brenneman, Nima Sharifai, Benjamin Fischer-Valuck, Comron Hassanzadeh, Jeffrey Guzelian, John S. A. Chrisinger, Jeff M. Michalski, Peter Oppelt, Brian C. Baumann
Published 2019-09-01
Article -
3
A pooled long-term follow-up after radiotherapy for prostate cancer with and without a rectal hydrogel spacer: impact of hydrogel on decline in sexual quality of life by Zachary A. Seymour, Zachary A. Seymour, Michael Pinkawa, Michael Pinkawa, Stephanie Daignault-Newton, Walter Bosch, Jeff M. Michalski, Hiram Gay, Daniel A. Hamstra, Daniel A. Hamstra
Published 2023-10-01
Article -
4
Concurrent paclitaxel and radiation therapy for the treatment of cutaneous angiosarcoma by Amit Roy, Prashant Gabani, Elizabeth J. Davis, Peter Oppelt, Emily Merfeld, Vicky L. Keedy, Imran Zoberi, John S.A. Chrisinger, Jeff M. Michalski, Brian Van Tine, Matthew B. Spraker
Published 2021-03-01
Article -
5
An Analysis of Major Target Deviations in Craniospinal Irradiation Treatment Plans for Patients With Intermediate-Risk Medulloblastoma Within a Phase 3 Clinical Trial (Children's O... by Joshua P. Schiff, MD, Yimei Lee, MS, Yu Wang, MS, Stephanie M. Perkins, MD, Sandy K. Kessel, MD, Thomas J. Fitzgerald, MD, Nicole A. Larrier, MD, Jeff M. Michalski, MD, MBA
Published 2023-01-01
Article -
6
Palliative radiation therapy (RT) for prostate cancer patients with bone metastases at diagnosis: A hospital‐based analysis of patterns of care, RT fractionation scheme, and overal... by Benjamin W. Fischer‐Valuck, Brian C. Baumann, Anthony Apicelli, Yuan James Rao, Michael Roach, Mackenzie Daly, Maria C. Dans, Patrick White, Jessika Contreras, Lauren Henke, Hiram Gay, Jeff M. Michalski, Christopher Abraham
Published 2018-09-01
Article -
7
Does the sequence of high-dose rate brachytherapy boost and IMRT for prostate cancer impact early toxicity outcomes? Results from a single institution analysis by Amit Roy, Randall J. Brenneman, Jacob Hogan, Justin M. Barnes, Yi Huang, Robert Morris, Sreekrishna Goddu, Michael Altman, Jose Garcia-Ramirez, Harold Li, Jacqueline E. Zoberi, Arnold Bullock, Eric Kim, Zachary Smith, Robert Figenshau, Gerald L. Andriole, Brian C. Baumann, Jeff M. Michalski, Hiram A. Gay
Published 2021-07-01
Article -
8
Effectiveness of postoperative radiotherapy after radical cystectomy for locally advanced bladder cancer by Benjamin W. Fischer‐Valuck, Jeff M. Michalski, Nandita Mitra, John P. Christodouleas, Todd A. DeWees, Eric Kim, Zachary L. Smith, Gerald L. Andriole, Vivek Arora, Arnold Bullock, Ruben Carmona, Robert S. Figenshau, Robert L. Grubb, Thomas J. Guzzo, Eric M. Knoche, S. Bruce Malkowicz, Ronac Mamtani, Russell K. Pachynski, Bruce J. Roth, Mohamed S. Zaghloul, Hiram A. Gay, Brian C. Baumann
Published 2019-07-01
Article -
9
A propensity analysis comparing definitive chemo-radiotherapy for muscle-invasive squamous cell carcinoma of the bladder vs. urothelial carcinoma of the bladder using the National... by Benjamin W. Fischer-Valuck, Jeff M. Michalski, Jessika A. Contreras, Randall Brenneman, John P. Christodouleas, Christopher D. Abraham, Eric H. Kim, Vivek K. Arora, Arnold D. Bullock, Ruben Carmona, Robert S. Figenshau, Robert Grubb, III, Eric M. Knoche, Russell K. Pachynski, Joel Picus, Bruce J. Roth, Paul Sargos, Gerald L. Andriole, Hiram A. Gay, Brian C. Baumann
Published 2019-02-01
Article -
10
Mapping expanded prostate cancer index composite to EQ5D utilities to inform economic evaluations in prostate cancer: Secondary analysis of NRG/RTOG 0415. by Rahul Khairnar, Stephanie L Pugh, Howard M Sandler, W Robert Lee, Ester Villalonga Olives, C Daniel Mullins, Francis B Palumbo, Deborah W Bruner, Fadia T Shaya, Soren M Bentzen, Amit B Shah, Shawn C Malone, Jeff M Michalski, Ian S Dayes, Samantha A Seaward, Michele Albert, Adam D Currey, Thomas M Pisansky, Yuhchyau Chen, Eric M Horwitz, Albert S DeNittis, Felix Y Feng, Mark V Mishra
Published 2021-01-01
Article -
11
Risk factors for late bowel and bladder toxicities in NRG Oncology prostate cancer trials of high-risk patients: A meta-analysis of physician-rated toxicities by Canhua Xiao, PhD, Jennifer Moughan, MS, Benjamin Movsas, MD, Andre A. Konski, MD, Gerald E. Hanks, MD, James D. Cox, MD, Mack Roach, III, MD, Kenneth L. Zeitzer, MD, Colleen A. Lawton, MD, Christopher A. Peters, MD, Seth A. Rosenthal, MD, I.-Chow Joe Hsu, MD, Eric M. Horwitz, MD, Mark V. Mishra, MD, Jeff M. Michalski, MD, Matthew B. Parliament, MD, David P. D'Souza, MD, Stephanie L. Pugh, PhD, Deborah W. Bruner, PhD
Published 2018-07-01
Article -
12
Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials by Andre Esteva, Jean Feng, Douwe van der Wal, Shih-Cheng Huang, Jeffry P. Simko, Sandy DeVries, Emmalyn Chen, Edward M. Schaeffer, Todd M. Morgan, Yilun Sun, Amirata Ghorbani, Nikhil Naik, Dhruv Nathawani, Richard Socher, Jeff M. Michalski, Mack Roach, Thomas M. Pisansky, Jedidiah M. Monson, Farah Naz, James Wallace, Michelle J. Ferguson, Jean-Paul Bahary, James Zou, Matthew Lungren, Serena Yeung, Ashley E. Ross, NRG Prostate Cancer AI Consortium, Howard M. Sandler, Phuoc T. Tran, Daniel E. Spratt, Stephanie Pugh, Felix Y. Feng, Osama Mohamad
Published 2022-06-01
Article -
13
Author Correction: Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials by Andre Esteva, Jean Feng, Douwe van der Wal, Shih-Cheng Huang, Jeffry P. Simko, Sandy DeVries, Emmalyn Chen, Edward M. Schaeffer, Todd M. Morgan, Yilun Sun, Amirata Ghorbani, Nikhil Naik, Dhruv Nathawani, Richard Socher, Jeff M. Michalski, Mack Roach, Thomas M. Pisansky, Jedidiah M. Monson, Farah Naz, James Wallace, Michelle J. Ferguson, Jean-Paul Bahary, James Zou, Matthew Lungren, Serena Yeung, Ashley E. Ross, NRG Prostate Cancer AI Consortium, Howard M. Sandler, Phuoc T. Tran, Daniel E. Spratt, Stephanie Pugh, Felix Y. Feng, Osama Mohamad
Published 2023-02-01
Article -
14
Future vision for the quality assurance of oncology clinical trials by Thomas eFitzGerald, MD, Thomas eFitzGerald, MD, Maryann eBishop-Jodoin, BS, Walter eBosch, DSc, Walter J. Curran, MD, David eFollowill, PhD, James M. Galvin, DSc, James M. Galvin, DSc, Richard eHanusik, AB, Steven R. King, MS, Michael V Knopp, MD, PhD, Fran eLaurie, BS, Elizabeth eO'Meara, BS, RT(R)(T), Jeff M. Michalski, MD, MBA, Joel H. Saltz, MD, PhD, Mitchell D. Schnall, MD, PhD, Lawrence eSchwartz, MD, Kenneth eUlin, PhD, Kenneth eUlin, PhD, Ying eXiao, PhD, Ying eXiao, PhD, Marcia M. Urie, PhD
Published 2013-03-01
Article